Cargando…

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy

BACKGROUND: It has been estimated that the incidence of chronic hepatitis C virus (HCV) will not decline over the next 10 years despite the improved efficacy of antiviral therapy because most patients remain undiagnosed and/or untreated. This study aimed to investigate the opinion of relevant target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreoni, Massimo, Coppola, Nicola, Craxì, Antonio, Fagiuoli, Stefano, Gardini, Ivan, Mangia, Alessandra, Nava, Felice Alfonso, Pasqualetti, Patrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725306/ https://www.ncbi.nlm.nih.gov/pubmed/34983405 http://dx.doi.org/10.1186/s12879-021-06983-y

Ejemplares similares

HCV and drug addiction in the historical scenario of infection entry in Italy
por: Massimo, Galli, et al.
Publicado: (2018)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Estimation of the number of HCV-positive patients in Italy
por: Gardini, Ivan, et al.
Publicado: (2019)

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
por: Andreoni, Massimo, et al.
Publicado: (2021)

Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study
por: Coppola, Carmine, et al.
Publicado: (2021)

HCV and immigration in Italy
por: Massimo, Galli, et al.
Publicado: (2018)

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2014)

Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy
por: D’Ambrosio, Roberta, et al.
Publicado: (2022)

Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study
por: Coppola, C., et al.
Publicado: (2021)

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions
por: Kondili, Loreta A., et al.
Publicado: (2022)

Epidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype: A systematic review and meta-analysis
por: Mancusi, Rossella Letizia, et al.
Publicado: (2016)

What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology
por: Tauscher, Justin S., et al.
Publicado: (2021)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Implementation of hcv screening in the 1969-1989 birth-cohort undergoing covid-19 vaccination: a pivotal study in Italy
por: D'Ambrosio, R., et al.
Publicado: (2022)

Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
por: Fagiuoli, Stefano, et al.
Publicado: (2023)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment
por: Fagiuoli, Stefano, et al.
Publicado: (2021)

Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
por: Getchell, Jane P., et al.
Publicado: (2013)

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
por: d'Arminio Monforte, Antonella, et al.
Publicado: (2017)

Update on epidemiology of HCV in Italy: focus on the Calabria Region
por: Marascio, Nadia, et al.
Publicado: (2014)

HCV infection and drug use in Italian detainees: results of validation of EQDP (European Questionnaire on Drug Use in Prison)
por: Felice, A. Nava
Publicado: (2018)

Health profiles and socioeconomic characteristics of nonagenarians residing in Mugello, a rural area in Tuscany (Italy)
por: Strozza, Cosmo, et al.
Publicado: (2020)

No strategy to meet the HCV epidemic
por: Dalgard, Olav, et al.
Publicado: (2014)

Rationing in a Pandemic: Lessons from Italy
por: Craxì, Lucia, et al.
Publicado: (2020)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

2549. Variance Between Clinicians and Guidelines in Management of HIV/HCV Coinfection
por: Naggie, Susanna, et al.
Publicado: (2019)

Time and Mode of Epidemic HCV-2 Subtypes Spreading in Europe: Phylodynamics in Italy and Albania
por: Ebranati, Erika, et al.
Publicado: (2021)

Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: results from a Department of Mental Health and Addiction of northern Italy
por: Capuzzi, Enrico, et al.
Publicado: (2020)

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
por: Mangia, Alessandra, et al.
Publicado: (2020)

Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study
por: Mangia, Alessandra, et al.
Publicado: (2021)

Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy
por: Ceci, Franca, et al.
Publicado: (2022)

Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection
por: Skočibušić, Siniša, et al.
Publicado: (2022)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Clinician and researcher – Can the twain ever meet? A young clinician's perspective
por: Prakash, Vaishnavi Batmanabane, et al.
Publicado: (2011)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Coordinated hospital-community organisation model for the prevention, monitoring and treatment of patients with addiction and HCV
por: Roberta, Balestra
Publicado: (2018)

Intolerance of uncertainty and conditioned place preference in opioid addiction
por: Radell, Milen L., et al.
Publicado: (2018)

Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d98rre4gb3h88l6cetak1onptp